FRANKFURT--The following is a summary of analysts' forecasts for
GlaxoSmithKline plc (GSK) second-quarter results, based on a poll
of eight analysts conducted by Dow Jones Newswires (figures in
million pound, EPS, dividend and target price in pence, according
to IFRS). Earnings figures are scheduled to be released July
29.
===
Core:
Turnover -operat. -Net attrib.
2nd Quarter total profit -PBT profit -EPS
AVERAGE 5,853 1,336 1,174 803 16.5
Prev. Year 5,561 1,407 1,259 921 19.1
+/- in % +5.3 -5.0 -6.7 -13 -14
MEDIAN 5,873 1,341 1,174 794 16.6
Maximum 5,955 1,402 1,242 844 17.5
Minimum 5,700 1,277 1,122 776 15.0
Amount 8 8 7 7 8
Bernstein 5,846 1,352 1,188 809 16.7
Credit Suisse 5,810 1,343 -- -- 15.0
Deutsche Bank 5,900 1,277 1,122 776 16.1
Jefferies 5,955 1,402 1,242 844 17.5
Kepler Cheuvreux 5,700 1,333 1,174 794 17.0
Mirabaud 5,804 1,338 1,166 790 16.4
Morgan Stanley 5,903 1,358 1,204 824 17.1
UBS 5,907 1,285 1,125 785 16.3
Target price Rating DPS 2015
AVERAGE 1.460 positive 0 AVERAGE 90.0
Prev. Quarter 1.567 neutral 4 Prev. Year 80.0
+/- in % -6.8 negative 0 +/- in % +13
MEDIAN 1.445 MEDIAN 90.0
Maximum 1.600 Maximum 100.0
Minimum 1.350 Minimum 80.0
Amount 4 Amount 4
Deutsche Bank 1.490 Hold 100.0
Jefferies 1.350 Hold 80.0
Morgan Stanley 1.600 Equalweight 100.0
UBS 1.400 Neutral 80.0
===
Year-earlier figures are as reported by the company.
DJG/voi
Subscribe to WSJ: http://online.wsj.com?mod=djnwires